Barclays Cuts Stake in Churchill Capital Corp X to 4.31%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 days ago
0mins
Should l Buy CCCX?
Source: stocktwits
- Stake Reduction Impact: Barclays has reduced its stake in Churchill Capital Corp X from 8.63% to 4.31%, representing a decrease of approximately 1.2 million shares, indicating a cautious market sentiment ahead of the upcoming merger vote that may undermine investor confidence.
- Merger Vote Approaches: Churchill Capital Corp X is set to hold a shareholder meeting on Thursday to seek approval for its merger with quantum technology firm Infleqtion, which is expected to close in Q1 2026, potentially generating over $540 million in gross proceeds for the company.
- NASA Partnership Incentive: Infleqtion's announcement of a partnership with NASA to launch the world's first quantum gravity sensor by 2030, backed by over $20 million in funding, highlights the broad application potential of quantum technology, which could enhance Churchill Capital's market appeal.
- Market Response Positive: Despite Barclays' stake reduction, shares of Churchill Capital fell over 5% in after-hours trading on Wednesday, yet the stock has seen gains of over 13% in regular trading for two consecutive days, reflecting optimistic market sentiment regarding the merger prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CCCX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CCCX
About CCCX
Churchill Capital Corp X is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in business operations nor generated any revenues.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Churchill Capital Corp X Shareholders Approve Merger with Infleqtion
- Shareholder Approval: Churchill Capital Corp X shareholders overwhelmingly supported the merger with Infleqtion, casting over 22.1 million votes in favor, which underscores strong confidence in the deal that is expected to deliver approximately $551 million in gross proceeds, enhancing its market position in quantum technology.
- Low Redemption Rate: The merger's redemption rate was remarkably low at just 0.09%, with only about 37,800 Class A shares redeemed, indicating investor trust in the merger and ensuring minimal capital outflow from the trust account, thereby stabilizing post-merger funding.
- Barclays Stake Reduction: Ahead of the vote, Barclays reduced its stake below the 5% reporting threshold, reflecting a cautious stance on the merger's prospects, having previously held 3 million shares, or 8.63%, which may influence market sentiment regarding the merger.
- Positive Market Reaction: Following the merger announcement, CCCX shares rose over 4% in after-hours trading, reflecting optimistic market sentiment towards Infleqtion, particularly in light of its partnership with NASA to develop a quantum gravity sensor, which has further fueled investor enthusiasm.
See More
Infleqtion Completes Business Combination with Churchill Capital Corp X
- Business Combination Completed: Infleqtion has successfully completed its business combination with Churchill Capital Corp X, marking its status as the first publicly listed neutral-atom quantum technology company, with trading expected to commence on the NYSE under the ticker “INFQ” on February 17, 2026.
- Technological Leadership: As a pioneer in neutral-atom technology, Infleqtion's product portfolio includes quantum computers, precision sensors, and quantum software, aimed at providing solutions for governments, enterprises, and research institutions, thus driving the commercialization of quantum technology.
- Wide Market Applications: Infleqtion's systems are utilized in collaboration with NVIDIA and have been adopted by clients including the U.S. Department of Defense, NASA, and the U.K. government, showcasing its commercial leadership in quantum computing and precision sensing, which is expected to drive future revenue growth.
- Strategic Implications: This merger not only enhances Infleqtion's market visibility but also provides it with a stronger competitive edge in the rapidly evolving quantum technology market, likely attracting more investor interest in its future growth potential.
See More
Infleqtion to Go Public as First Neutral-Atom Quantum Tech Company in 2026
- Public Listing Milestone: Infleqtion is set to begin trading on the NYSE on February 17, 2026, under the ticker symbol 'INFQ', marking a significant milestone as the first publicly listed neutral-atom quantum technology company, which could enhance investor interest and market visibility.
- Successful Business Combination: The completion of Infleqtion's merger with Churchill Capital Corp X has led to the delisting of Churchill's shares from Nasdaq, with Infleqtion's common stock and warrants expected to trade on the NYSE, thereby solidifying its market position and operational footprint.
- Technological Leadership: As a pioneer in neutral-atom technology, Infleqtion designs and sells quantum computers and precision sensors to high-profile clients such as the U.S. Department of Defense and NASA, showcasing its competitive edge and commercial viability in the advanced quantum technology sector.
- Expansive Market Potential: Infleqtion's commercial platform is engineered to cater to both quantum computing and precision sensing needs, which is anticipated to attract a broader range of government and enterprise clients, thereby reinforcing the company's leadership in the rapidly evolving quantum technology market.
See More
Churchill Capital Corp X Shareholders Approve Infleqtion Merger
- Shareholder Approval: Churchill Capital Corp X shareholders have approved the merger with Infleqtion, which is expected to provide over $550 million in gross proceeds, ensuring nearly 100% cash inflow and raising over $125 million in incremental capital through a PIPE, reflecting strong market confidence in quantum technology.
- First Public Quantum Company: Upon completion of the merger, Infleqtion will become the first publicly listed neutral-atom quantum technology company, marking a significant milestone that will enhance its market position in quantum computing and attract more investor interest.
- Delisting from Nasdaq: Churchill X will delist from Nasdaq, while the merged Infleqtion's common stock and warrants will be listed on the New York Stock Exchange starting February 17, 2026, under the ticker symbols “INFQ” and “INFQ WS”, signifying a new phase in the company's growth.
- Transaction Closing Date: The transaction is expected to close on February 13, 2026, and this merger will not only drive Infleqtion's technological advancements but also provide broader market opportunities for its applications in government, enterprise, and research institutions.
See More
Churchill X Shareholders Approve Merger with Infleqtion
- Strong Shareholder Support: Churchill X shareholders overwhelmingly approved the merger with Infleqtion at a special meeting, with over 90% voting in favor, indicating strong confidence and expected to provide Infleqtion with over $550 million in funding to enhance its market competitiveness.
- Diverse Funding Sources: The transaction will include nearly 100% of the trust cash and over $125 million in new capital, ensuring Infleqtion is well-capitalized post-merger to support its technology roadmap and product commercialization.
- Enhanced Market Position: Following the merger, Infleqtion will become the first publicly listed neutral-atom quantum technology company, holding a commercial leadership position in quantum computing and precision sensing, which is expected to drive applications in artificial intelligence and national security.
- Listing Changes and Compliance: Upon completion of the merger, Churchill X will delist from Nasdaq and list on the New York Stock Exchange on February 17, 2026, marking a significant structural shift for the company and enhancing its market profile.
See More
Infleqtion Announces Merger with Churchill Capital Corp X for Public Offering
- Recognition of Leadership: Infleqtion's founder and Chief Science Officer, Dr. Dana Anderson, has been inducted into the National Academy of Engineering for his contributions to optical quantum engineering of ultracold atoms, highlighting the company's leadership in quantum technology and likely attracting increased investor interest.
- Advancement of IPO Plans: Infleqtion plans to go public through a merger with Churchill Capital Corp X in 2025, which will provide essential funding to accelerate the commercialization of its quantum computing and sensing technologies.
- Accumulation of Scientific Achievements: Dr. Anderson has published over 100 scientific papers and received multiple awards, including Fellow status in the American Physical Society and the Optical Society of America, enhancing Infleqtion's academic reputation and providing robust support for its technological innovations.
- Expansive Market Outlook: With the ongoing development of quantum technology, Infleqtion's product portfolio, including quantum computers and precision sensors, is expected to meet the growing demand from governments and enterprises for advanced quantum capabilities, positioning the company favorably in a rapidly expanding market.
See More
Churchill Capital Corp X Shareholders Approve Merger with Infleqtion
- Shareholder Approval: Churchill Capital Corp X shareholders overwhelmingly supported the merger with Infleqtion, casting over 22.1 million votes in favor, which underscores strong confidence in the deal that is expected to deliver approximately $551 million in gross proceeds, enhancing its market position in quantum technology.
- Low Redemption Rate: The merger's redemption rate was remarkably low at just 0.09%, with only about 37,800 Class A shares redeemed, indicating investor trust in the merger and ensuring minimal capital outflow from the trust account, thereby stabilizing post-merger funding.
- Barclays Stake Reduction: Ahead of the vote, Barclays reduced its stake below the 5% reporting threshold, reflecting a cautious stance on the merger's prospects, having previously held 3 million shares, or 8.63%, which may influence market sentiment regarding the merger.
- Positive Market Reaction: Following the merger announcement, CCCX shares rose over 4% in after-hours trading, reflecting optimistic market sentiment towards Infleqtion, particularly in light of its partnership with NASA to develop a quantum gravity sensor, which has further fueled investor enthusiasm.
See More
Infleqtion Completes Business Combination with Churchill Capital Corp X
- Business Combination Completed: Infleqtion has successfully completed its business combination with Churchill Capital Corp X, marking its status as the first publicly listed neutral-atom quantum technology company, with trading expected to commence on the NYSE under the ticker “INFQ” on February 17, 2026.
- Technological Leadership: As a pioneer in neutral-atom technology, Infleqtion's product portfolio includes quantum computers, precision sensors, and quantum software, aimed at providing solutions for governments, enterprises, and research institutions, thus driving the commercialization of quantum technology.
- Wide Market Applications: Infleqtion's systems are utilized in collaboration with NVIDIA and have been adopted by clients including the U.S. Department of Defense, NASA, and the U.K. government, showcasing its commercial leadership in quantum computing and precision sensing, which is expected to drive future revenue growth.
- Strategic Implications: This merger not only enhances Infleqtion's market visibility but also provides it with a stronger competitive edge in the rapidly evolving quantum technology market, likely attracting more investor interest in its future growth potential.
See More
Infleqtion to Go Public as First Neutral-Atom Quantum Tech Company in 2026
- Public Listing Milestone: Infleqtion is set to begin trading on the NYSE on February 17, 2026, under the ticker symbol 'INFQ', marking a significant milestone as the first publicly listed neutral-atom quantum technology company, which could enhance investor interest and market visibility.
- Successful Business Combination: The completion of Infleqtion's merger with Churchill Capital Corp X has led to the delisting of Churchill's shares from Nasdaq, with Infleqtion's common stock and warrants expected to trade on the NYSE, thereby solidifying its market position and operational footprint.
- Technological Leadership: As a pioneer in neutral-atom technology, Infleqtion designs and sells quantum computers and precision sensors to high-profile clients such as the U.S. Department of Defense and NASA, showcasing its competitive edge and commercial viability in the advanced quantum technology sector.
- Expansive Market Potential: Infleqtion's commercial platform is engineered to cater to both quantum computing and precision sensing needs, which is anticipated to attract a broader range of government and enterprise clients, thereby reinforcing the company's leadership in the rapidly evolving quantum technology market.
See More
Churchill Capital Corp X Shareholders Approve Infleqtion Merger
- Shareholder Approval: Churchill Capital Corp X shareholders have approved the merger with Infleqtion, which is expected to provide over $550 million in gross proceeds, ensuring nearly 100% cash inflow and raising over $125 million in incremental capital through a PIPE, reflecting strong market confidence in quantum technology.
- First Public Quantum Company: Upon completion of the merger, Infleqtion will become the first publicly listed neutral-atom quantum technology company, marking a significant milestone that will enhance its market position in quantum computing and attract more investor interest.
- Delisting from Nasdaq: Churchill X will delist from Nasdaq, while the merged Infleqtion's common stock and warrants will be listed on the New York Stock Exchange starting February 17, 2026, under the ticker symbols “INFQ” and “INFQ WS”, signifying a new phase in the company's growth.
- Transaction Closing Date: The transaction is expected to close on February 13, 2026, and this merger will not only drive Infleqtion's technological advancements but also provide broader market opportunities for its applications in government, enterprise, and research institutions.
See More
Churchill X Shareholders Approve Merger with Infleqtion
- Strong Shareholder Support: Churchill X shareholders overwhelmingly approved the merger with Infleqtion at a special meeting, with over 90% voting in favor, indicating strong confidence and expected to provide Infleqtion with over $550 million in funding to enhance its market competitiveness.
- Diverse Funding Sources: The transaction will include nearly 100% of the trust cash and over $125 million in new capital, ensuring Infleqtion is well-capitalized post-merger to support its technology roadmap and product commercialization.
- Enhanced Market Position: Following the merger, Infleqtion will become the first publicly listed neutral-atom quantum technology company, holding a commercial leadership position in quantum computing and precision sensing, which is expected to drive applications in artificial intelligence and national security.
- Listing Changes and Compliance: Upon completion of the merger, Churchill X will delist from Nasdaq and list on the New York Stock Exchange on February 17, 2026, marking a significant structural shift for the company and enhancing its market profile.
See More
Infleqtion Announces Merger with Churchill Capital Corp X for Public Offering
- Recognition of Leadership: Infleqtion's founder and Chief Science Officer, Dr. Dana Anderson, has been inducted into the National Academy of Engineering for his contributions to optical quantum engineering of ultracold atoms, highlighting the company's leadership in quantum technology and likely attracting increased investor interest.
- Advancement of IPO Plans: Infleqtion plans to go public through a merger with Churchill Capital Corp X in 2025, which will provide essential funding to accelerate the commercialization of its quantum computing and sensing technologies.
- Accumulation of Scientific Achievements: Dr. Anderson has published over 100 scientific papers and received multiple awards, including Fellow status in the American Physical Society and the Optical Society of America, enhancing Infleqtion's academic reputation and providing robust support for its technological innovations.
- Expansive Market Outlook: With the ongoing development of quantum technology, Infleqtion's product portfolio, including quantum computers and precision sensors, is expected to meet the growing demand from governments and enterprises for advanced quantum capabilities, positioning the company favorably in a rapidly expanding market.
See More
